bpc-157 legal status research chemical Heal or Harm: Body Protective Compound-157 in the Gray Zone BPC-157 10MG Research Peptide
Description
MOTS-C works by activating the AMP-activated protein kinase (AMPK) pathway, a central energy-sensing mechanism that promotes glucose uptake, fatty acid oxidation, and insulin sensitivity
A scientific basis for clinical care
Insulin and insulin secretagogues (sulfonylureas such as glipizide, glyburide, or meglitinides) pose a significant hypoglycemia risk when combined with Zepbound
The study showed that the brain also contained the compound, although the concentration was the lowest there
